Despite improvements in surgical & oncological management, pancreatic cancer has a dismal prognosis. While the Australian Pancreatic Centre prides itself on better survival outcomes for patients, breakthroughs in treatment are desperately needed. The Centre’s involvement with research into the basic sciences and translation of these findings into treatments for patients is essential for changing the paradigm for pancreatic cancer patients. The Centre partners with the Bill Walsh Translational Cancer Research Laboratory as a vehicle for driving this research. It also currently supports the work of Surgical Research Fellow, Dr Chris Nahm.
The Bill Walsh Translational Cancer Research Laboratory was established in 1980 and is located in the Kolling Building at Royal North Shore Hospital. It is the research arm of the Medical Oncology Department. It is part of the Hormones and Cancer Division of the Kolling Institute, which is affiliated with Sydney Medical School at the University of Sydney and is a member of Sydney Vital, a Cancer Institute NSW Translational Cancer Research Centre.
The team of medical oncologists and cancer researchers work together to fast-track discoveries into clinical practice. The focus is on increasing understanding of cancer biology, identifying better ways to diagnose and predict how a cancer will behave, and improving cancer treatment for better outcomes for cancer patients.